{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:28:09Z","timestamp":1793377689161,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.acra.2026.03.006","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T21:37:20Z","timestamp":1774388240000},"page":"2709-2719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Head-to-head Comparison of Fibroblast Activation Protein Inhibitors and 18F-fluorodeoxyglucose in Cervical Cancer: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1058-5394","authenticated-orcid":false,"given":"Tengfei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqi","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2026.03.006_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.acra.2026.03.006_bib2","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(25)01188-2","article-title":"Partial progress in sexual and reproductive health and rights: the influence of sociocultural, behavioural, structural, and technological changes on epidemiological trends","volume":"406","author":"Grulich","year":"2025","journal-title":"The Lancet"},{"key":"10.1016\/j.acra.2026.03.006_bib3","article-title":"The prognostic value of baseline 18FDG \u2013 positron emission tomography \u2013 computed tomography in cervical cancer patients treated with definitive chemoradiotherapy \u2013 external multicentre validation model","volume":"35","author":"Staniewska","year":"2025","journal-title":"Phys\u00a0Imaging Radiat\u00a0Oncol"},{"key":"10.1016\/j.acra.2026.03.006_bib4","article-title":"Diagnostic performance of quantitative measures from [18F]FDG PET\/CT, [18F]FEC PET\/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING study","author":"King","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.acra.2026.03.006_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/biomedicines13010083","article-title":"PET CT imaging with FDG in the therapeutical management of locally advanced cervical cancer diagnosed in a 43-year-old patient: case report and review of the literature","volume":"13","author":"Molnar","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.acra.2026.03.006_bib6","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.3390\/jcm13237445","article-title":"Assessing the efficacy of 18F FDG PET-CT in preoperative staging of early-stage cervical cancer in Novi Sad, Serbia\u2014a pilot study","volume":"13","author":"Malenkovi\u0107","year":"2024","journal-title":"JCM"},{"key":"10.1016\/j.acra.2026.03.006_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/jimaging11020063","article-title":"Unraveling the role of PET in cervical cancer: review of current applications and future horizons","volume":"11","author":"Yadav","year":"2025","journal-title":"J Imaging"},{"key":"10.1016\/j.acra.2026.03.006_bib8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1148\/rg.2017160059","article-title":"FDG PET\/CT pitfalls in gynecologic and genitourinary oncologic imaging","volume":"37","author":"Lakhani","year":"2017","journal-title":"RadioGraphics"},{"key":"10.1016\/j.acra.2026.03.006_bib9","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.7150\/thno.69475","article-title":"Fibroblast activation protein-based theranostics in cancer research: a state-of-the-art review","volume":"12","author":"Zhao","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.acra.2026.03.006_bib10","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.3390\/cancers13225744","article-title":"Radioligands targeting fibroblast activation protein (FAP)","volume":"13","author":"Lindner","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.acra.2026.03.006_bib11","article-title":"68 Ga FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"1","author":"Hathi","year":"2019","journal-title":"Radiology: Imaging Cancer"},{"key":"10.1016\/j.acra.2026.03.006_bib12","first-page":"983","article-title":"18F-FAPI-04 PET\/CT in the evaluation of patients with cervical cancers: head-to-head comparison with 18F-FDG PET\/CT","volume":"50","author":"Wei","year":"2025","journal-title":"Clin\u00a0Nucl\u00a0Med"},{"key":"10.1016\/j.acra.2026.03.006_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40644-025-00843-7","article-title":"Head-to-head comparison of 18F-FDG and 68Ga-FAPI PET\/CT in common gynecological malignancies","volume":"25","author":"Li","year":"2025","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.acra.2026.03.006_bib14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00259-023-06539-z","article-title":"Comparison of the diagnostic value of [68 Ga]Ga-FAPI-04 PET\/MR and [18F]FDG PET\/CT in patients with T stage \u2264 2a2 uterine cervical cancer: a prospective study","volume":"51","author":"Lyu","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.acra.2026.03.006_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/RLU.0000000000004505","article-title":"First clinical experience with [68Ga]Ga-FAPI-46-PET\/CT versus [18F]F-FDG PET\/CT for nodal staging in cervical cancer","volume":"48","author":"Wegen","year":"2023","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.acra.2026.03.006_bib16","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/RLU.0000000000004833","article-title":"Head-to-head comparison of 18F-FDG and 68Ga-FAPI-04 PET\/CT for radiological evaluation of cervical cancer","volume":"48","author":"Shu","year":"2023","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.acra.2026.03.006_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/RLU.0000000000003968","article-title":"Uterine uptake of 68Ga-FAPI-04 in uterine pathology and physiology","volume":"47","author":"Zhang","year":"2022","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.acra.2026.03.006_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2025.2556714","article-title":"Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts","volume":"14","author":"Polten","year":"2025","journal-title":"OncoImmunology"},{"key":"10.1016\/j.acra.2026.03.006_bib19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3724\/abbs.2022132","article-title":"Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-\u03b2\/Smad pathway","volume":"55","author":"Yang","year":"2023","journal-title":"ABBS"},{"key":"10.1016\/j.acra.2026.03.006_bib20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/cells13070560","article-title":"Phenotypic heterogeneity of cancer associated fibroblasts in cervical cancer progression: FAP as a central activation marker","volume":"13","author":"Bueno-Urquiza","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.acra.2026.03.006_bib21","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.acra.2026.03.006_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acra.2026.03.006_bib23","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1007\/s00259-025-07277-0","article-title":"Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis","volume":"52","author":"Florit","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.acra.2026.03.006_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/RLU.0000000000003939","article-title":"68Ga-FAPI PET\/CT distinguishes the reactive lymph nodes from tumor metastatic lymph nodes in a patient with nasopharyngeal carcinoma","volume":"47","author":"Shang","year":"2022","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.acra.2026.03.006_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/RLU.0000000000003968","article-title":"Uterine uptake of 68Ga-FAPI-04 in uterine pathology and physiology","volume":"47","author":"Zhang","year":"2022","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.acra.2026.03.006_bib26","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2967\/jnumed.121.262808","article-title":"Pitfalls and common findings in68 Ga-FAPI PET: a pictorial analysis","volume":"63","author":"Kessler","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2026.03.006_bib27","first-page":"438","article-title":"Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: do negative findings on PET-CT negativity really indicate node negativity?","volume":"166","author":"Kim","year":"2022","journal-title":"Gynecol\u00a0Oncol"},{"key":"10.1016\/j.acra.2026.03.006_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11307-025-02011-6","article-title":"Physiological uptake of 68Ga-FAPI-04 in female reproductive system","volume":"27","author":"Mu","year":"2025","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"10.1016\/j.acra.2026.03.006_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-02041-6","article-title":"Radiopharmaceuticals and their applications in medicine","volume":"10","author":"Zhang","year":"2025","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.acra.2026.03.006_bib30","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1097\/RLU.0000000000005728","article-title":"177Lu-FAPI-2286 therapy in a patient with radio-iodine refractory papillary thyroid carcinoma: a favorable clinical and biochemical response","volume":"50","author":"Raeisi","year":"2025","journal-title":"Clinical Nuclear Medicine"},{"key":"10.1016\/j.acra.2026.03.006_bib31","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1097\/RLU.0000000000004021","article-title":"177Lu-FAPI therapy in a patient with end-stage metastatic pancreatic adenocarcinoma","volume":"47","author":"Kaghazchi","year":"2022","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.acra.2026.03.006_bib32","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1097\/RLU.0000000000005255","article-title":"First experience of radionuclide therapy with 177Lu-FAPI-2286 in a patient with metastatic mediastinal sarcoma","volume":"49","author":"Banihashemian","year":"2024","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.acra.2026.03.006_bib33","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00259-024-06943-z","article-title":"Preoperative assessment of pancreatic cancer with [68Ga]Ga-DOTA-FAPI-04 PET\/MR versus [18F]-FDG PET\/CT plus contrast-enhanced CT: a prospective preliminary study","volume":"52","author":"Zhang","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.acra.2026.03.006_bib34","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/RLU.0000000000005342","article-title":"The added value of contrast-enhanced 68Ga-FAPI-04 PET\/MRI over 18F-FDG PET\/CT in hepatocellular carcinoma","volume":"49","author":"Ding","year":"2024","journal-title":"Clin Nucl Med"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226001704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226001704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:47:40Z","timestamp":1778759260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633226001704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1076633226001704"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.03.006","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Head-to-head Comparison of Fibroblast Activation Protein Inhibitors and 18F-fluorodeoxyglucose in Cervical Cancer: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}